Risk factors
Atossa Therapeutics (ATOS) risk factors
Item 1A of every Atossa Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors58 risks
Atossa Therapeutics faces substantial going concern doubts and requires significant additional capital to advance its lead drug, (Z)-endoxifen.
Filed Mar 25, 2026